Context Therapeutics

CNTXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$44.470 M

$0.48 -3.97%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$36.1M

Loss-making

Shares outstanding

91,879,177

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#356Edesa BiotechEDSA$46.9M
#357Mereo BioPharma GroupMREO$46.0M
#358Context TherapeuticsCNTX$44.5M
#359PDS BiotechnologyPDSB$43.4M
#360Hyperion DefiHYPD$40.9M

Where these numbers come from

Share counts and financials for Context Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.